RELMADA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Relmada Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2012 to Q4 2023.
  • Relmada Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $110M, a 5.38% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $110M -$6.26M -5.38% Dec 31, 2023 10-K 2024-03-19
Q4 2022 $116M +$20.2M +21% Dec 31, 2022 10-K 2024-03-19
Q4 2021 $96.2M +$45.8M +90.8% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $50.4M +$24.5M +94.3% Dec 31, 2020 10-K 2022-03-25
Q4 2019 $26M Dec 31, 2019 10-K 2021-03-24
Q2 2019 $23.3M +$4.36M +23% Jun 30, 2019 10-K 2021-03-24
Q2 2018 $18.9M -$235K -1.23% Jun 30, 2018 10-KT 2020-03-26
Q2 2017 $19.2M +$4.65M +32% Jun 30, 2017 10-K 2018-09-28
Q2 2016 $14.5M +$3.75M +34.8% Jun 30, 2016 10-K 2017-09-28
Q2 2015 $10.8M +$2.74M +34.2% Jun 30, 2015 10-K 2016-09-09
Q2 2014 $8.03M Jun 30, 2014 10-K 2015-09-11
Q4 2013 $3.29M +$1.1M +50.3% Dec 31, 2013 10-KT 2014-09-09
Q3 2013 -$7.2K* -$2.08K Aug 31, 2013 10-K 2013-12-16
Q4 2012 $2.19M Dec 31, 2012 8-K 2014-05-27
Q3 2012 -$5.12K* Aug 31, 2012 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.